logo
Plus   Neg
Share
Email

EARNINGS SUMMARY: Details of Nektar Therapeutics Q3 Earnings Report

Below are the earnings highlights for Nektar Therapeutics (NKTR):

-Earnings: -$98.81 million in Q3 vs. -$96.14 million in the same period last year.
-EPS: -$0.56 in Q3 vs. -$0.56 in the same period last year.
-Analysts projected -$0.73 per share
-Revenue: $29.22 million in Q3 vs. $27.76 million in the same period last year.

For comments and feedback contact: editorial@rttnews.com

Follow RTT
>